COST-Action EU-METAHEART Training School and Conference 2024

COST-Action EU-METAHEART Training School and Conference 2024

The COST-Action EU-METAHEART Training School and Conference will be held in Würzburg, Germany, from September 8-13, 2024. The first three days will feature expert-led sessions, workshops, and practical courses on Ionoptix, Oroboros, and Seahorse methodologies, along with a special lecture on “Building Your Career in Science.”

This will be followed by a two-day conference with poster sessions and keynote lectures on cardiovascular diseases and heart failure.

Topics will include cardio-immune interfaces, the metabolic impact of coronary vascular dysfunction, immunometabolism and a keynote on targeting histone deacetylases to treat heart failure. Join us for a week of cutting-edge science and collaboration.

Share this post

Twitter
Facebook
LinkedIn
WhatsApp

Latest Updates

Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage

New Insights into Cardiac Amyloidosis Mechanisms and Therapies

WG2 Online Meeting

Newsletter

Subscribe our Newsletter and stay up-to-date

Stay Up-to-date

New Research Highlight from EU-METAHEART consortium “Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage” by Panagiota-Efstathia Nicolau, Ioanna Andreadou and collaborators. The study...
A recent publication co-authored by core members of the EU-METAHEART COST Action focuses on the multifaceted mechanisms driving cardiac amyloidosis and explores potential therapeutic avenues. The paper, entitled “Mechanisms of...
As WG2 leaders, Luca Liberale, Bruno Podesser, and Gerd Heusch presented the scope and objectives of the METAHEART COST action, focusing on WG2 activities. The update covered recent group developments...
Dear colleagues, For a recently approved grant, I am currently looking for a post-doc with expertise on data science in exercise/muscle physiology, with a specific focus on Long COVID. The postdoc...
The MDC offers a highly vibrant scientific environment, with state-of-the-art infrastructure for immunological platforms such as flow cytometry, single-cell transcriptomics, spatial transcriptomics, metabolomics and proteomics, imaging, and in vivo work....
The 1st paper of the EU-METAHEART COST Action was published in European Heart Journal: https://doi.org/10.1093/eurheartj/ehae457 Take a look!